CompletedNot Applicable

Prevalence of ESBL and CPE in French Nursing Homes

France734 participantsStarted 2018-10-03

Plain-language summary

CARBEHPAD is a multicentric randomized prevalence study aiming to assess the frequency of Enterobacteriaceae (ESLB) and carbapenemase producing Enterobacteriaceae (CPE) carriage in Pays de la Loire nursing homes. A sample of 50 nursing homes (NH) in Pays de la Loire will be randomly selected for inclusion, and a sample of 1/3 of residents of these NH will be screened for ESBL and/or CPE fecal carriage. Epidemiological data on each resident will be collected to identify risk factors for such carriage.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Resident present in the nursing home on the day of the survey. * Resident having agreed to be included in the study. * Resident with a social security number. Exclusion Criteria: \- Resident non-compliant with sampling protocol.

What they're measuring

carbapenemase producing Enterobacteriaceae (CPE) carriage

Timeframe: six months

Trial details

NCT IDNCT03401242

SponsorNantes University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-01-14

View on ClinicalTrials.gov More Enterobacteriaceae Infections trials